2025 Global Blood Culture Tests Market Revenue Opportunities Report
Description
The 2025 Global Blood Culture Tests Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Culture Tests Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global blood culture tests market are Abbott Laboratories, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company (BD), and Beckman Coulter. Abbott Laboratories holds the largest market share of around 24.35%, followed by Thermo Fisher Scientific with 12%, Becton Dickinson with 8.13%, and Beckman Coulter with about 5.76% of the global market, collectively accounting for over 50% of the market share. These companies focus on innovations in rapid pathogen detection technologies, antimicrobial susceptibility testing, and expanding global distribution networks.
These companies lead by continuously investing in research, launching automated and rapid diagnostic platforms, and forming strategic partnerships to bolster their market positions. Abbott and BD have broadened their portfolios through acquisitions and new technologies, such as BD’s integrated blood culture solutions and bioMérieux’s rapid AST systems. Their strong presence in North America and expanding footprints in emerging Asia-Pacific markets reflect their global engagement in addressing the rising incidence of bloodstream infections and sepsis. Their emphasis on faster testing times, digital integration, and enhanced accuracy helps meet increasing global demand in hospital and reference laboratories.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Culture Tests Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global blood culture tests market are Abbott Laboratories, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company (BD), and Beckman Coulter. Abbott Laboratories holds the largest market share of around 24.35%, followed by Thermo Fisher Scientific with 12%, Becton Dickinson with 8.13%, and Beckman Coulter with about 5.76% of the global market, collectively accounting for over 50% of the market share. These companies focus on innovations in rapid pathogen detection technologies, antimicrobial susceptibility testing, and expanding global distribution networks.
These companies lead by continuously investing in research, launching automated and rapid diagnostic platforms, and forming strategic partnerships to bolster their market positions. Abbott and BD have broadened their portfolios through acquisitions and new technologies, such as BD’s integrated blood culture solutions and bioMérieux’s rapid AST systems. Their strong presence in North America and expanding footprints in emerging Asia-Pacific markets reflect their global engagement in addressing the rising incidence of bloodstream infections and sepsis. Their emphasis on faster testing times, digital integration, and enhanced accuracy helps meet increasing global demand in hospital and reference laboratories.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
